Search
Now showing items 1-6 of 6
Vaccine vectors and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2015-02-17)
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...
Compositions and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2013-12-10)
Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
Compositions and methods of enhancing immune responses to flagellated bacterium
(United States. Patent and Trademark Office, 2015-09-08)
Vaccines comprising fliC and CD 154 polypeptides and Salmonella enteritidis vaccine vectors comprising fliC polypeptides are provided. Also provided arc methods of enhancing an immune response against flagellated bacteria ...
Compositions and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2018-06-26)
Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
Vaccine vectors and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2018-03-13)
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2020-10-06)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...